Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 28 | 2024 | 939 | 4.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 11 | 2023 | 518 | 1.810 |
Why?
|
Mucin-5B | 7 | 2023 | 148 | 1.480 |
Why?
|
Respiratory System Abnormalities | 4 | 2023 | 67 | 1.370 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 8 | 2024 | 3247 | 0.810 |
Why?
|
Pulmonary Fibrosis | 5 | 2023 | 503 | 0.700 |
Why?
|
Tomography, X-Ray Computed | 27 | 2024 | 20659 | 0.670 |
Why?
|
Lung | 26 | 2023 | 10033 | 0.620 |
Why?
|
Polymorphism, Genetic | 4 | 2017 | 4247 | 0.570 |
Why?
|
Pulmonary Emphysema | 5 | 2021 | 683 | 0.540 |
Why?
|
Smoking | 5 | 2023 | 9081 | 0.410 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2709 | 0.410 |
Why?
|
Iceland | 4 | 2020 | 183 | 0.390 |
Why?
|
Bronchiectasis | 2 | 2022 | 141 | 0.330 |
Why?
|
Promoter Regions, Genetic | 4 | 2019 | 5786 | 0.310 |
Why?
|
Cause of Death | 2 | 2020 | 3708 | 0.260 |
Why?
|
Genetic Testing | 2 | 2021 | 3595 | 0.250 |
Why?
|
Lung Injury | 2 | 2021 | 430 | 0.240 |
Why?
|
Disease Progression | 5 | 2024 | 13632 | 0.230 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1896 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 6 | 2023 | 18071 | 0.200 |
Why?
|
Atherosclerosis | 1 | 2017 | 3424 | 0.190 |
Why?
|
Incidental Findings | 2 | 2024 | 697 | 0.190 |
Why?
|
Myositis | 1 | 2024 | 270 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 169 | 0.180 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 135 | 0.170 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12509 | 0.170 |
Why?
|
Hernia, Hiatal | 1 | 2020 | 90 | 0.160 |
Why?
|
Emphysema | 1 | 2021 | 234 | 0.160 |
Why?
|
Pulmonary Artery | 2 | 2024 | 1935 | 0.160 |
Why?
|
Lung Diseases | 2 | 2022 | 1940 | 0.160 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 413 | 0.150 |
Why?
|
Humans | 50 | 2024 | 765968 | 0.150 |
Why?
|
Pneumonectomy | 1 | 2024 | 1128 | 0.140 |
Why?
|
Logistic Models | 4 | 2019 | 13266 | 0.140 |
Why?
|
Telomere | 1 | 2022 | 943 | 0.130 |
Why?
|
Mechanotransduction, Cellular | 1 | 2021 | 540 | 0.120 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1216 | 0.120 |
Why?
|
Cohort Studies | 10 | 2024 | 41649 | 0.120 |
Why?
|
Aged | 23 | 2024 | 171117 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 276 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1365 | 0.110 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13451 | 0.110 |
Why?
|
DNA | 2 | 2018 | 7202 | 0.110 |
Why?
|
Male | 28 | 2024 | 363698 | 0.110 |
Why?
|
Survival Rate | 4 | 2021 | 12795 | 0.110 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 833 | 0.100 |
Why?
|
Middle Aged | 23 | 2024 | 223009 | 0.100 |
Why?
|
Prevalence | 5 | 2024 | 15842 | 0.100 |
Why?
|
Respiratory Function Tests | 4 | 2020 | 1693 | 0.100 |
Why?
|
Female | 28 | 2024 | 396112 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 744 | 0.100 |
Why?
|
Spirometry | 3 | 2021 | 929 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59489 | 0.090 |
Why?
|
Critical Illness | 1 | 2024 | 2744 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 684 | 0.090 |
Why?
|
Age Factors | 4 | 2021 | 18380 | 0.080 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14751 | 0.080 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2598 | 0.080 |
Why?
|
ROC Curve | 1 | 2017 | 3620 | 0.080 |
Why?
|
Family | 1 | 2020 | 3209 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1964 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39193 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12056 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12807 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3733 | 0.070 |
Why?
|
Genetic Markers | 1 | 2014 | 2601 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 54802 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 13024 | 0.060 |
Why?
|
Self Report | 1 | 2018 | 3770 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7875 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5446 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 6919 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4080 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8731 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8875 | 0.050 |
Why?
|
Traction | 1 | 2022 | 112 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16047 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 995 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 207 | 0.050 |
Why?
|
Bronchoalveolar Lavage | 1 | 2021 | 131 | 0.040 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 471 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8923 | 0.040 |
Why?
|
beta Karyopherins | 1 | 2019 | 46 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 198 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2024 | 841 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7584 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29922 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2021 | 827 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 22223 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2021 | 700 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 81514 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15880 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15652 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1187 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6544 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2070 | 0.030 |
Why?
|
Autoantibodies | 1 | 2024 | 2113 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1458 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1545 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4526 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1828 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2595 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 586 | 0.020 |
Why?
|
Adult | 6 | 2024 | 223044 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4137 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8733 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3800 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4241 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2056 | 0.020 |
Why?
|
Decision Making | 1 | 2024 | 3965 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2631 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2880 | 0.020 |
Why?
|
Palliative Care | 1 | 2024 | 3645 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20124 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5876 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9649 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3910 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3430 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2415 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13462 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10383 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10070 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7232 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6897 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14448 | 0.020 |
Why?
|
MicroRNAs | 1 | 2021 | 3785 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81819 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 74840 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8297 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18293 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14652 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5937 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10850 | 0.010 |
Why?
|
United States | 2 | 2020 | 72903 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40065 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168764 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21480 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24282 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23601 | 0.010 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(58)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_